Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-23-009352

Options or other derivatives

  • Chief Medical Officer acquired 142,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Harris Matthew Scott Chief Medical Officer 2023-01-30 Grant or award · Stock Options (option to buy) +105,000 105,000 D
Harris Matthew Scott Chief Medical Officer 2023-01-30 Grant or award · Restricted Stock Units +37,100 37,100 D
Loading xslF345X03/tm235142-1_4seq1.xml…